Press Releases

To schedule a media interview with Arun Menawat, Chief Executive Officer, a urologist or a patient, please contact:

Sanam Riahi

Marketing Director

647.476.1350, Ext. 439

2016

Profound Medical Corp. Announces Third Quarter 2016 Financial Results

November 16, 2016

Profound Medical Corp. Completes Previously Announced $17.4 Million Bought Deal Offering of Common Shares

November 14, 2016

Profound Medical Corp. to Present at the 2016 Canaccord Genuity Medical Technologies & Diagnostic Forum

November 3, 2016

Profound Medical Corp. to Present at the Stifel 2016 Healthcare Conference

November 1, 2016

Profound Medical Corp. to Release Third Quarter 2016 Financial Results on November 16, 2016 – Conference Call to Follow

October 26, 2016

Profound Medical Corp. Announces $17.4 Million Bought Deal Financing

October 17, 2016

Profound Medical Receives Frost & Sullivan’s 2016 New Product Innovation Award

October 5, 2016

Profound Medical Corp. Announces First Patient Treated in TACT Pivotal Clinical Trial at Vanderbilt University Medical Center

September 22, 2016

Profound Medical Corp. Announces Second Quarter 2016 Financial Results

August 18, 2016

Profound Medical names Arun Menawat as CEO

August 16, 2016

Profound Medical Corp. Announces Senior Management Changes to Support Global Growth Strategy 

August 15, 2016

Mackie starts Profound Medical at speculative buy

August 10, 2016

Profound Medical Corp. to Release Second Quarter 2016 Financial Results on August 18, 2016

August 10, 2016

Profound Medical Corp. Announces Annual Meeting of Shareholders Voting Results

June 22, 2016

Profound Medical Corp. and Philips Sell TULSA-PROTM System to Cologne, Germany

June 21, 2016

Profound Medical Corp, and Philips Sell TULSA-PROTM System to UCL and UCLH

June 20, 2016

Revolutionizing Prostate Cancer Treatment, investinontario.com

June 2016

Profound Medical Corp. to hold Annual General Meeting of the Shareholders

June 7, 2016

FDA Grants Profound Medical Corp. IDE Approval for TULSA-PROTM

May 19, 2016

Profound Medical Corp. and Philips sign Sales and Marketing Agreement in MRI-guided therapy for Prostate Cancer Care

May 11, 2016

Profound Medical Corp. Announces First Quarter 2016 Financial Results

May 6, 2016

Profound Medical Corp. to Present at Upcoming Conference 

April 29, 2016

Profound Medical Corp. to Release First Quarter 2016 Financial Results on May 6, 2016

April 29, 2016

Profound Medical Corp. Announces World’s First Sale of TULSA-PRO for Prostate Ablation

April 28, 2016

Profound Earns European Approval for Prostate Device

April 21, 2016

GMP Securities starts Profound Medical at speculative buy

April 13, 2016

Profound Medical Corp., receives CE Mark Approval for TULSA-PRO

April 11, 2016

Best Poster at EAU 2016 Munich for the session, Localized prostate cancer: Innovative strategies in active surveillance and focal therapy

March 12, 2016

Profound Medical Corp. and Siemens Enter Into Strategic Agreement to Further the Development of Prostate Cancer Care

February 29, 2016

Profound Medical Corp. to Release Full Year 2015 Financial Results on March 3, 2016

February 25, 2016

Profound Medical Corp., Announces Publication in European Urology

January 8, 2016, Press Release

2015

Profound Medical named 2016 Life Science Company of the Year

November 27, 2015, Press Release

A Brighter Future: Advancements in Prostate Therapy Minimize Side Effects for Patients

November 20, 2015, Media Planet Supplement, Toronto Star

Profound Medical Corp. Announces Departure of CFO

November 17, 2015, Press Release 

Things to Consider When Going Public

OnBoard Magazine Fall 2015

Profound Medical Corp. Announces Third Quarter 2015 Financial Results

November 4, 2015, Press Release

Hartmut Warnken joins Profound Medical as Vice President, International Sales

November 2, 2015, Press Release

Profound Medical Corp. to Release Third Quarter 2015 Financial Results on November 4, 2015

October 28, 2015, Press Release

Profound Medical to Present at Upcoming Investor Conferences

October 21, 2015, Press Release

Profound Medical Presents Successful 12-Month Phase 1 Outcomes at the European Symposium on Focused Ultrasound Therapy

October 15, 2015, Press Release

Profound Medical to Present 12-month outcomes of Phase 1 Clinical Trial at European Symposium on Focused Ultrasound Therapy News

October 13, 2015, Press Release

Profound Medical Announces Grant of Share Options

September 18, 2015, Press Release

Profound Medical Corp. Announces Second Quarter 2015 Financial Results

August 25, 2015, Press Release

Profound Medical Corp. Announces First Quarter 2015 Financial Results of Profound Medical Inc.

July 29, 2015, Press Release

Philips and Profound Medical Collaborate to Advance Treatment for Prostate Cancer Patients

July 21, 2015, Press Release

Profound Medical Corp. Announces Annual Meeting of Shareholders Voting Results

June 23, 2015, Press Release

Profound Medical Opens the Market

June 15, 2015, Press Release

Profound Medical Goes Public via Reverse Takeover

June 1, Biotechnology Focus

Profound Medical Corp. Announces Closing of Qualifying Transaction

June 4, 2015, Press Release

Preclinical safety and feasibility with 28-day follow-up

May 2015, Journal of Urology, Vol. 192

Profound Medical seeking CE Mark for TULSA-PRO This Year

May 26, 2015, Bio Tuesdays

Profound Medical and Shopify show Contrasting Ways to go Public

May 25, 2015, Financial Post

Mira IV Acquisition Corp. Announces Filing of Filing Statement

May 25, 2015, Press Release

PMI Announces Going-Public Transaction and Concurrent $28 Million Financing to Fund Next Stage of Growth

April 30, 2015, Press Release

Mira IV Acquisition Corp. Announces entering into of an Amalgamation Agreement with PMI

April 29, 2105, Press Release

CEO Steve Plymale participates in panel: Meet the Entrepreneurs – Health

April 15, 2015, MaRS video

Tips for Working with the FDA

OnBoard Magazine, Page 23, Spring 2015

Best Poster for Session, New Technologies in the OR, EAU 2015

March 2015, EAU Madrid

Newsroom2x

Upcoming Events

Meet Profound Medical at these Meetings and Conferences

seperator-profound-sm

EAU 2017, London, UK

March 24-28, 2017

AUA 2017, Boston, US 

May 12-16, 2017